Open AccessGuillain-Barre Syndrome with Covid-19 Infection
Author(s) -
Savita Bansiram Pohekar,
Amruta Kothe
Publication year - 2021
Publication title -
journal of evolution of medical and dental sciences
Language(s) - English
Resource type - Journals
eISSN - 2278-4802
pISSN - 2278-4748
DOI - 10.14260/jemds/2021/437
Subject(s) - medicine , guillain barre syndrome , weakness , etiology , pediatrics , cytomegalovirus , immunology , virus , surgery , viral disease , herpesviridae
COVID-19 from Wuhan, China has spread easily all over the world. Most of the COVID-19 infected patients have fever and breathing disorders. Here, we report a case of Guillain-Barre syndrome (GBS) with a COVID-19 infection. GBS is a very rare disease with corona virus infection. It is really hard to diagnose. In this state the limbs of the patient are slowly weakened. The condition worsens daily with weakness of the limbs. The Guillain-Barre syndrome is a complex and acute or chronic neurological condition. Campylobacter jejuni and other viruses, including cytomegalovirus and Epstein Barr Virus, are causing this condition.1 It is a disorder that is progressive, symmetric, proximate, distal, and characterised by weakness. Muscle reflexes are reduced to absent. Aetiology is unclear, Death is uncommon. The diagnosis of GBS can be made by cerebrospinal fluid analysis and nerve conduction studies.2 We present a case of Guillain-Barre syndrome with COVID-19 infection, who presented to the emergency Outpatient department with complaints of weakness against his bilateral upper and lower limb.